Literature DB >> 9683162

Latanoprost-associated cystoid macular edema.

D Callanan1, R L Fellman, J A Savage.   

Abstract

PURPOSE: To report two cases in which cystoid macular edema developed after initiation of topical latanoprost for glaucoma.
METHODS: Case reports. One pseudophakic eye in each of two patients treated with latanoprost for glaucoma developed decreased vision and cystoid macular edema. Latanoprost was discontinued, and the cystoid macular edema was treated with topical corticosteroids and ketorolac.
RESULTS: After discontinuing latanoprost and starting corticosteroids and ketorolac, visual acuity improved from counting fingers to 20/60 in one patient's left eye and from 20/100 to 20/25 in the other patient's right eye. The macular edema resolved in both eyes.
CONCLUSIONS: Topical latanoprost may be associated with cystoid macular edema; this may be related to a prostaglandin-like action.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9683162     DOI: 10.1016/s0002-9394(98)00082-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  12 in total

Review 1.  Efficacy and adverse effects of medications used in the treatment of glaucoma.

Authors:  C B Camras; C B Toris; R R Tamesis
Journal:  Drugs Aging       Date:  1999-11       Impact factor: 3.923

Review 2.  Pharmacological therapy for glaucoma: a review.

Authors:  P F Hoyng; L M van Beek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

Review 3.  A preliminary risk-benefit assessment of latanoprost and unoprostone in open-angle glaucoma and ocular hypertension.

Authors:  D L Eisenberg; C B Camras
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

Review 4.  Management of glaucoma: focus on pharmacological therapy.

Authors:  Robert E Marquis; Jess T Whitson
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost.

Authors:  K Kashiwagi; S Tsukahara
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

6.  Travoprost in the management of open-angle glaucoma and ocular hypertension.

Authors:  Philippe Denis; David Covert; Anthony Realini
Journal:  Clin Ophthalmol       Date:  2007-03

7.  First-year treatment costs among new initiators of topical prostaglandin analogs.

Authors:  Jordana K Schmier; David W Covert; Alan L Robin
Journal:  Clin Ophthalmol       Date:  2009-11-16

Review 8.  Drug-induced macular edema.

Authors:  Olga E Makri; Ilias Georgalas; Constantine D Georgakopoulos
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

Review 9.  Latanoprost : an update of its use in glaucoma and ocular hypertension.

Authors:  Caroline M Perry; Jane K McGavin; Christine R Culy; Tim Ibbotson
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Successful treatment of prostaglandin-induced cystoid macular edema with subtenon triamcinolone.

Authors:  Kazuki Matsuura; Shinichi Sasaki; Ryu Uotani
Journal:  Clin Ophthalmol       Date:  2012-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.